Umbilical Vessel Catheters Market Size, Share & Trends Analysis Report By Product (Umbilical Arterial Catheters, Umbilical Venous Catheters), By Material (Silicone-based Catheters, PVC-coated Catheters), By Channel, By Indication/Use, By End Use, By Region, And Segment Forecasts, 2025 - 2033
The global umbilical vessel catheters market size was estimated at USD 550.56 million in 2024 and is projected to reach USD 887.45 million by 2033, growing at a CAGR of 5.56% from 2025 to 2033. The industry is driven by several key factors, including the rising incidence of preterm births and the growing need for advanced neonatal intensive care worldwide. Increasing investments in healthcare infrastructure and NICU capacity have enhanced access to specialized vascular access devices for newborns.
The rising incidence of preterm births is a primary factor driving the growth of the umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further reinforce market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.
The growing need for advanced neonatal intensive care is a major factor driving the umbilical vessel catheters market. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.
Technological innovations, like antimicrobial-coated catheters, are further enhancing adoption by reducing infection risks and improving patient safety. Furthermore, the growing awareness among healthcare professionals of early neonatal interventions and infection control practices continues to drive global market growth. The integration of imaging-guided insertion techniques and real-time monitoring systems is enhancing precision and reducing procedural complications. Moreover, ongoing product development by key manufacturers is expanding the availability of advanced, cost-effective solutions for neonatal care worldwide.
Global Umbilical Vessel Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global umbilical vessel catheters market report based on product, material, channel, indication/use, end use, and region:
The rising incidence of preterm births is a primary factor driving the growth of the umbilical vessel catheters industry. Preterm infants often require immediate and reliable vascular access for administering fluids, medications, and parenteral nutrition in neonatal intensive care units (NICUs). Umbilical vessel catheters (UVCs and UACs) play a crucial role in stabilizing these infants during the critical early stages of life. With increasing global preterm birth rates and improved survival outcomes, the demand for advanced, safe, and infection-resistant catheters continues to rise. Moreover, growing awareness among healthcare professionals and the expansion of neonatal care infrastructure further reinforce market growth worldwide. According to the Reproductive Health Journal, the number of preterm births remained high globally, with an estimated 13.4 million cases in 2020. According to the Centers for Disease Control and Prevention (CDC), both early and late preterm birth rates increased by 4% from 2020 to 2021 but later declined by 1%-2% from 2021 to 2022.
The growing need for advanced neonatal intensive care is a major factor driving the umbilical vessel catheters market. As the number of preterm and low-birth-weight infants continues to rise, the demand for reliable and safe vascular access solutions has increased significantly. Umbilical vessel catheters play a crucial role in delivering essential medications, fluids, and nutrition while allowing continuous monitoring of critically ill newborns. The expansion of neonatal intensive care units (NICUs) and the adoption of advanced medical technologies are further enhancing their use. In addition, the focus on improving neonatal survival rates and reducing complications is accelerating the adoption of high-performance, infection-resistant catheters across hospitals worldwide.
Technological innovations, like antimicrobial-coated catheters, are further enhancing adoption by reducing infection risks and improving patient safety. Furthermore, the growing awareness among healthcare professionals of early neonatal interventions and infection control practices continues to drive global market growth. The integration of imaging-guided insertion techniques and real-time monitoring systems is enhancing precision and reducing procedural complications. Moreover, ongoing product development by key manufacturers is expanding the availability of advanced, cost-effective solutions for neonatal care worldwide.
Global Umbilical Vessel Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global umbilical vessel catheters market report based on product, material, channel, indication/use, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Umbilical Arterial Catheters (UACs)
- Umbilical Venous Catheters (UVCs)
- Material Outlook (Revenue, USD Million, 2021 - 2033)
- Polyurethane-based Catheters
- Silicone-based Catheters
- PVC-coated Catheters
- Others
- Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Single Lumen
- Double Lumen
- Triple Lumen
- Indication/Use Outlook (Revenue, USD Million, 2021 - 2033)
- Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
- Exchange Blood Transfusion
- Cardiac Catheterisation
- Parenteral Nutrition
- Drug Administration
- Frequent Blood Sampling/Arterial Blood Gas Monitoring
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals (NICUs)
- Specialty Clinics or Centers
- Ambulatory Surgery Centers
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Material
1.1.3. Indication/Use
1.1.4. Channel
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. UMBILICAL VESSEL CATHETERS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of preterm births
3.2.1.2. Growing neonatal intensive care admissions
3.2.1.3. Increased focus on neonatal survival rates
3.2.2. Market restraint analysis
3.2.2.1. Short duration of use
3.2.2.2. High cost of advanced catheters
3.2.3. Market opportunity analysis
3.2.3.1. Rising demand for single-use and sterile products
3.2.3.2. Integration of imaging and guidance systems
3.2.3.3. Emerging markets expansion
3.2.4. Market challenge analysis
3.2.4.1. High risk of infection and complications
3.2.4.2. Difficulty in accurate catheter placement
3.3. Umbilical Vessel Catheters Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
CHAPTER 4. UMBILICAL VESSEL CATHETERS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Umbilical Vessel Catheters Market Product Movement Analysis
4.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Umbilical Arterial Catheters (UACs)
4.4.1. Umbilical arterial catheters (UACs) market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Umbilical Venous Catheters (UVCs)
4.5.1. Umbilical venous catheters (UVCs) market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 5. UMBILICAL VESSEL CATHETERS MARKET: MATERIAL ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Umbilical Vessel Catheters Market Material Movement Analysis
5.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
5.4. Polyurethane-based Catheters
5.4.1. Polyurethane-based catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Silicone-based Catheters
5.5.1. Silicone-based catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.6. PVC-coated Catheters
5.6.1. PVC-coated catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 6. UMBILICAL VESSEL CATHETERS MARKET: CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Umbilical Vessel Catheters Market Channel Movement Analysis
6.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Channel, 2021 to 2033 (USD Million)
6.4. Single Lumen
6.4.1. Single lumen market estimates and forecasts for 2021 to 2033 (USD Million)
6.5. Double Lumen
6.5.1. Double lumen market estimates and forecasts for 2021 to 2033 (USD Million)
6.6. Triple Lumen
6.6.1. Triple lumen market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 7. UMBILICAL VESSEL CATHETERS MARKET: INDICATION/USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Umbilical Vessel Catheters Market Indication/Use Movement Analysis
7.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Indication/Use, 2021 to 2033 (USD Million)
7.4. Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
7.4.1. Neonates with difficult venous access (DVA) for emergency resuscitation market estimates and forecasts for 2021 to 2033 (USD Million)
7.5. Exchange Blood Transfusion
7.5.1. Exchange blood transfusion market estimates and forecasts for 2021 to 2033 (USD Million)
7.6. Cardiac Catheterisation
7.6.1. Cardiac catheterisation market estimates and forecasts for 2021 to 2033 (USD Million)
7.7. Parenteral Nutrition
7.7.1. Parenteral nutrition market estimates and forecasts for 2021 to 2033 (USD Million)
7.8. Drug Administration
7.8.1. Drug administration market estimates and forecasts for 2021 to 2033 (USD Million)
7.9. Frequent blood sampling/arterial blood gas monitoring
7.9.1. Frequent blood sampling/arterial blood gas monitoring market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 8. UMBILICAL VESSEL CATHETERS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Global Umbilical Vessel Catheters Market End Use Movement Analysis
8.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Hospitals (NICUs)
8.4.1. Hospitals (NICUs) market estimates and forecasts for 2021 to 2033 (USD Million)
8.5. Specialty Clinics or Centers
8.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
8.6. Ambulatory Surgery Centers
8.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 9. UMBILICAL VESSEL CATHETERS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory framework
9.4.1.4. Reimbursement scenario
9.4.1.5. UK market estimates and forecasts, 2021 - 2033
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. France market estimates and forecasts, 2021 - 2033
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Competitive scenario
9.5.1.3. Regulatory framework
9.5.1.4. Reimbursement scenario
9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
9.5.2. India
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. India market estimates and forecasts, 2021 - 2033
9.5.3. China
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. China market estimates and forecasts, 2021 - 2033
9.5.4. South Korea
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
9.5.5. Australia
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
9.7. Middle East & Africa
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Global Key company market share analysis, 2024
10.3.4. Vygon
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Utah Medical Products, Inc.
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Cardinal Health
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Haolang Technology (Foshan) Limited Co., Ltd
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Polymed
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Sterimed Group
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. ANGIPLAST PRIVATE LIMITED
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Romsons
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Laborie
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. AMECATH
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.4. Heat Map Analysis/ Company Market Position Analysis
10.5. Estimated Company Market Share Analysis, 2024
10.6. List of Other Key Market Players
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Material
1.1.3. Indication/Use
1.1.4. Channel
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. UMBILICAL VESSEL CATHETERS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of preterm births
3.2.1.2. Growing neonatal intensive care admissions
3.2.1.3. Increased focus on neonatal survival rates
3.2.2. Market restraint analysis
3.2.2.1. Short duration of use
3.2.2.2. High cost of advanced catheters
3.2.3. Market opportunity analysis
3.2.3.1. Rising demand for single-use and sterile products
3.2.3.2. Integration of imaging and guidance systems
3.2.3.3. Emerging markets expansion
3.2.4. Market challenge analysis
3.2.4.1. High risk of infection and complications
3.2.4.2. Difficulty in accurate catheter placement
3.3. Umbilical Vessel Catheters Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
CHAPTER 4. UMBILICAL VESSEL CATHETERS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Umbilical Vessel Catheters Market Product Movement Analysis
4.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Umbilical Arterial Catheters (UACs)
4.4.1. Umbilical arterial catheters (UACs) market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Umbilical Venous Catheters (UVCs)
4.5.1. Umbilical venous catheters (UVCs) market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 5. UMBILICAL VESSEL CATHETERS MARKET: MATERIAL ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Umbilical Vessel Catheters Market Material Movement Analysis
5.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
5.4. Polyurethane-based Catheters
5.4.1. Polyurethane-based catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Silicone-based Catheters
5.5.1. Silicone-based catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.6. PVC-coated Catheters
5.6.1. PVC-coated catheters market estimates and forecasts for 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 6. UMBILICAL VESSEL CATHETERS MARKET: CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Umbilical Vessel Catheters Market Channel Movement Analysis
6.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Channel, 2021 to 2033 (USD Million)
6.4. Single Lumen
6.4.1. Single lumen market estimates and forecasts for 2021 to 2033 (USD Million)
6.5. Double Lumen
6.5.1. Double lumen market estimates and forecasts for 2021 to 2033 (USD Million)
6.6. Triple Lumen
6.6.1. Triple lumen market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 7. UMBILICAL VESSEL CATHETERS MARKET: INDICATION/USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Global Umbilical Vessel Catheters Market Indication/Use Movement Analysis
7.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by Indication/Use, 2021 to 2033 (USD Million)
7.4. Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation
7.4.1. Neonates with difficult venous access (DVA) for emergency resuscitation market estimates and forecasts for 2021 to 2033 (USD Million)
7.5. Exchange Blood Transfusion
7.5.1. Exchange blood transfusion market estimates and forecasts for 2021 to 2033 (USD Million)
7.6. Cardiac Catheterisation
7.6.1. Cardiac catheterisation market estimates and forecasts for 2021 to 2033 (USD Million)
7.7. Parenteral Nutrition
7.7.1. Parenteral nutrition market estimates and forecasts for 2021 to 2033 (USD Million)
7.8. Drug Administration
7.8.1. Drug administration market estimates and forecasts for 2021 to 2033 (USD Million)
7.9. Frequent blood sampling/arterial blood gas monitoring
7.9.1. Frequent blood sampling/arterial blood gas monitoring market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 8. UMBILICAL VESSEL CATHETERS MARKET: END USE ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Global Umbilical Vessel Catheters Market End Use Movement Analysis
8.3. Global Umbilical Vessel Catheters Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Hospitals (NICUs)
8.4.1. Hospitals (NICUs) market estimates and forecasts for 2021 to 2033 (USD Million)
8.5. Specialty Clinics or Centers
8.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
8.6. Ambulatory Surgery Centers
8.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
CHAPTER 9. UMBILICAL VESSEL CATHETERS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory framework
9.4.1.4. Reimbursement scenario
9.4.1.5. UK market estimates and forecasts, 2021 - 2033
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. France market estimates and forecasts, 2021 - 2033
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Competitive scenario
9.5.1.3. Regulatory framework
9.5.1.4. Reimbursement scenario
9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
9.5.2. India
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. India market estimates and forecasts, 2021 - 2033
9.5.3. China
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. China market estimates and forecasts, 2021 - 2033
9.5.4. South Korea
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
9.5.5. Australia
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
9.7. Middle East & Africa
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Global Key company market share analysis, 2024
10.3.4. Vygon
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Utah Medical Products, Inc.
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Cardinal Health
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Haolang Technology (Foshan) Limited Co., Ltd
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Polymed
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Sterimed Group
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. ANGIPLAST PRIVATE LIMITED
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Romsons
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Laborie
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. AMECATH
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.4. Heat Map Analysis/ Company Market Position Analysis
10.5. Estimated Company Market Share Analysis, 2024
10.6. List of Other Key Market Players
LIST OF TABLES
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Umbilical Vessel Catheters Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Umbilical Vessel Catheters Market, for Product, 2021 - 2033 (USD Million)
Fig. 15 Global Umbilical Vessel Catheters Market, for Umbilical Arterial Catheters (UACs), 2021 - 2033 (USD Million)
Fig. 16 Global Umbilical Vessel Catheters Market, for Umbilical Venous Catheters (UVCs), 2021 - 2033 (USD Million)
Fig. 17 Global Umbilical Vessel Catheters Market, for Material 3, 2021 - 2033 (USD Million)
Fig. 18 Global Umbilical Vessel Catheters Market, for Polyurethane-based Catheters, 2021 - 2033 (USD Million)
Fig. 19 Global Umbilical Vessel Catheters Market, for Silicone-based Catheters, 2021 - 2033 (USD Million)
Fig. 20 Global Umbilical Vessel Catheters Market, for PVC-coated Catheters, 2021 - 2033 (USD Million)
Fig. 21 Global Umbilical Vessel Catheters Market, for Others, 2021 - 2033 (USD Million)
Fig. 22 Global Umbilical Vessel Catheters Market, for Channel, 2021 - 2033 (USD Million)
Fig. 23 Global Umbilical Vessel Catheters Market, for Single Lumen, 2021 - 2033 (USD Million)
Fig. 24 Global Umbilical Vessel Catheters Market, for Double Lumen, 2021 - 2033 (USD Million)
Fig. 25 Global Umbilical Vessel Catheters Market, for Triple Lumen, 2021 - 2033 (USD Million)
Fig. 26 Global Umbilical Vessel Catheters Market, for Indication/Use, 2021 - 2033 (USD Million)
Fig. 27 Global Umbilical Vessel Catheters Market, for Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation, 2021 - 2033 (USD Million)
Fig. 28 Global Umbilical Vessel Catheters Market, for Exchange Blood Transfusion, 2021 - 2033 (USD Million)
Fig. 29 Global Umbilical Vessel Catheters Market, for Cardiac Catheterisation, 2021 - 2033 (USD Million)
Fig. 30 Global Umbilical Vessel Catheters Market, for Parenteral Nutrition, 2021 - 2033 (USD Million)
Fig. 31 Global Umbilical Vessel Catheters Market, for Drug Administration, 2021 - 2033 (USD Million)
Fig. 32 Global Umbilical Vessel Catheters Market, for Frequent Blood Sampling/Arterial Blood Gas Monitoring, 2021 - 2033 (USD Million)
Fig. 33 Global Umbilical Vessel Catheters Market, for End Use, 2021 - 2033 (USD Million)
Fig. 34 Global Umbilical Vessel Catheters Market, for Hospitals (NICUs), 2021 - 2033 (USD Million)
Fig. 35 Global Umbilical Vessel Catheters Market, for Specialty Clinics or Centers, 2021 - 2033 (USD Million)
Fig. 36 Global Umbilical Vessel Catheters Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
Fig. 37 Regional Outlook, 2024 & 2033
Fig. 38 North America Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 39 U.S. Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 40 Canada Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 41 Mexico Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 42 Europe Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 43 Germany Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 44 UK Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 45 France Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 46 Italy Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 47 Spain Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 48 Denmark Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 49 Sweden Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 50 Norway Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 51 Asia Pacific Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 52 Japan Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 53 China Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 54 India Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 55 Australia Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 56 South Korea Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 57 Thailand Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 58 Latin America Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 59 Brazil Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 60 Argentina Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 61 Middle East and Africa Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 62 South Africa Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 63 Saudi Arabia Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 64 UAE Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 65 Kuwait Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Umbilical Vessel Catheters Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 Market Challenge Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Umbilical Vessel Catheters Market, for Product, 2021 - 2033 (USD Million)
Fig. 15 Global Umbilical Vessel Catheters Market, for Umbilical Arterial Catheters (UACs), 2021 - 2033 (USD Million)
Fig. 16 Global Umbilical Vessel Catheters Market, for Umbilical Venous Catheters (UVCs), 2021 - 2033 (USD Million)
Fig. 17 Global Umbilical Vessel Catheters Market, for Material 3, 2021 - 2033 (USD Million)
Fig. 18 Global Umbilical Vessel Catheters Market, for Polyurethane-based Catheters, 2021 - 2033 (USD Million)
Fig. 19 Global Umbilical Vessel Catheters Market, for Silicone-based Catheters, 2021 - 2033 (USD Million)
Fig. 20 Global Umbilical Vessel Catheters Market, for PVC-coated Catheters, 2021 - 2033 (USD Million)
Fig. 21 Global Umbilical Vessel Catheters Market, for Others, 2021 - 2033 (USD Million)
Fig. 22 Global Umbilical Vessel Catheters Market, for Channel, 2021 - 2033 (USD Million)
Fig. 23 Global Umbilical Vessel Catheters Market, for Single Lumen, 2021 - 2033 (USD Million)
Fig. 24 Global Umbilical Vessel Catheters Market, for Double Lumen, 2021 - 2033 (USD Million)
Fig. 25 Global Umbilical Vessel Catheters Market, for Triple Lumen, 2021 - 2033 (USD Million)
Fig. 26 Global Umbilical Vessel Catheters Market, for Indication/Use, 2021 - 2033 (USD Million)
Fig. 27 Global Umbilical Vessel Catheters Market, for Neonates with Difficult Venous Access (DVA) for Emergency Resuscitation, 2021 - 2033 (USD Million)
Fig. 28 Global Umbilical Vessel Catheters Market, for Exchange Blood Transfusion, 2021 - 2033 (USD Million)
Fig. 29 Global Umbilical Vessel Catheters Market, for Cardiac Catheterisation, 2021 - 2033 (USD Million)
Fig. 30 Global Umbilical Vessel Catheters Market, for Parenteral Nutrition, 2021 - 2033 (USD Million)
Fig. 31 Global Umbilical Vessel Catheters Market, for Drug Administration, 2021 - 2033 (USD Million)
Fig. 32 Global Umbilical Vessel Catheters Market, for Frequent Blood Sampling/Arterial Blood Gas Monitoring, 2021 - 2033 (USD Million)
Fig. 33 Global Umbilical Vessel Catheters Market, for End Use, 2021 - 2033 (USD Million)
Fig. 34 Global Umbilical Vessel Catheters Market, for Hospitals (NICUs), 2021 - 2033 (USD Million)
Fig. 35 Global Umbilical Vessel Catheters Market, for Specialty Clinics or Centers, 2021 - 2033 (USD Million)
Fig. 36 Global Umbilical Vessel Catheters Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
Fig. 37 Regional Outlook, 2024 & 2033
Fig. 38 North America Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 39 U.S. Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 40 Canada Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 41 Mexico Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 42 Europe Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 43 Germany Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 44 UK Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 45 France Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 46 Italy Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 47 Spain Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 48 Denmark Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 49 Sweden Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 50 Norway Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 51 Asia Pacific Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 52 Japan Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 53 China Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 54 India Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 55 Australia Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 56 South Korea Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 57 Thailand Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 58 Latin America Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 59 Brazil Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 60 Argentina Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 61 Middle East and Africa Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 62 South Africa Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 63 Saudi Arabia Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 64 UAE Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
Fig. 65 Kuwait Umbilical Vessel Catheters Market, 2021 - 2033 (USD Million)
